WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'3201 Infant (under 12 months) mortality rate: 582
GDP / capita (US$): 1'8521 Child (under 5 years) mortality rate: 892

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 188  183  178  173  168  139  117  95 
Births
Surviving infants
Pop. less than 5 years 31  30  29  29  28  22  20  19 
Pop. less than 15 years 78  76  74  72  70  61  56  45 
Female 15-49 years 46  45  44  43  42  33  24  19 

Number of reported case

(Click for retrospective incidence data for Sao Tome and Principe)
Diphtheria
Japanese encephalitis
Measles 10  519 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 12 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sao Tome and Principe)
Vaccine year result method % card seen                                                
BCG 2007  96  DHS   93.0  99  99  99  99  100  81  100 
DTP1 2007  94  DHS   93.0  98  98  98  90  99 
DTP3 2007  87  DHS   93.0  96  96  98  98  99  82  92 
HepB_BD         
HepB3 2006  94  EPI   97.3  96  96  98  98  99 
Hib3          96  96  98 
JapEnc         
MCV 2007  84  DHS   93.0  92  91  93  90  93  69  71 
MCV2         
PCV1          64 
PCV3         
Pol3 2007  87  DHS   93.0  96  96  98  99  99  87  90 
Rota1         
Rota_last         
Rubella1         
TT2plus 2006  95  EPI   97.3  92  90  87  90  88  75  65 
PAB         
VAD1          91  90  80  80  24 
YFV 2006  86  EPI   97.3  92  91  93  90  93 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sao Tome and Principe)
BCG 99  99  99  99  99  81  99 
DTP1 98  98  98  99  99  89  97 
DTP3 96  96  98  98  99  82  92 
HepB3 96  96  98  98  99 
Hib3 96  96  98 
MCV 92  91  92  90  93  69  71 
PCV3
Pol3 96  96  98  99  99  87  90 
Rota_last
YFV 93  92  93  91  94 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
HepB birth; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; 17 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Td 1st contact; +1, +6 months; +1, +2 years; Yes
VitaminA 6, 12, 18, 24, 30,36 months; Yes and postpartum
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2008-2012  2008-2012  2008-2012  2003/2007  2003-2007 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  Yes  No         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 29  43  29  71     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  No  Yes  Yes  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 15  25  46  50 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.